How much does a PE healthcare culture-integration retainer cost?

IHS does not publish a fee schedule for the Integral PE-Rollup Culture-Integration Retainer (C2). The retainer is scoped per platform — calibrated to anticipated acquisition cadence, platform-level base scope, and the depth of per-acquisition intensive support required. The reference benchmark for human-capital advisory at this level is Bain and BCG day rates for PE operating-model consulting, which run $5,000-$10,000 per consultant per day. The C2 retainer is principal-delivered by a single practitioner with a rare credential intersection (JD, PhD, CCEP), structured as an ongoing retainer rather than per-day billing, and calibrated to the full 12-24 month hold-period scope. Contact IHS for a tailored proposal.

What does a PE operating partner consultant charge per day?

Senior consultants at Bain, McKinsey, and BCG bill PE clients at $5,000-$10,000 per consultant per day for operating-model and value-creation work. Operating partners at PE firms are typically compensated at $500,000-$2,000,000+ annually in total compensation (salary plus carry) for in-house portfolio-company support. An external human-capital retainer that addresses the human-layer integration work the operating team cannot reach — clinical attrition, founder-clinician grief, compounding relational debt — is measured against these reference points.

What factors drive the cost of a PE culture-integration retainer up or down?

Primary cost drivers: acquisition pace (entities per year), platform leadership team size, depth of founder-clinician transition work per entity, mid-level leader integration complexity, and whether the platform starts the retainer before its first acquisition or mid-cycle with accumulated integration debt. Factors that reduce scope: playbook maturity across the hold period (per-activation cost decreases as the playbook compounds), entities with low cultural distance from the platform, and platforms with a strong internal CHRO who absorbs coordination logistics.

What is the cost of not engaging a culture-integration retainer for a PE healthcare platform?

70-90% of M&A deals fail to deliver projected value (MIT Sloan Management Review). Only 14% of healthcare M&A reaches successful integration (Bain, via VALUWIT). 65% of acquiring companies cite cultural issues as hampering post-merger operations (PwC). For a platform acquiring 5-30 entities over a 3-7 year hold period, the cost of repeated human-layer failure — clinical attrition, founder-clinician departure, mid-level dysfunction, governance fragmentation — is measured in exit-multiple erosion, LP scrutiny of workforce risk, and the compounding cost of each unresolved integration carried into the next acquisition.

Is the retainer billed as a monthly fee or per-acquisition?

The retainer runs in two concurrent tracks. The platform-level track — quarterly health review, playbook maintenance, senior leadership team work — is billed as a platform base that runs continuously regardless of acquisition pace. The per-acquisition intensive (90-120 days per entity) is a separate activation fee that deploys when a new entity closes. Platforms that acquire more entities than anticipated do not pay the platform base twice — they pay the per-acquisition activation fee for each additional entity.

What budget line item does this retainer fall under for a PE platform?

PE platforms typically classify culture-integration retainers under portfolio-company operating costs (charged to the platform company), management company operating expenses, or deal-level integration costs allocated to each acquisition at close. The per-acquisition intensive portion can be structured as a deal cost allocated to each acquired entity, consistent with how most platforms classify integration consulting. The engagement letter accommodates either allocation approach. IHS defers to the platform's LP reporting and fund accounting conventions.

How does the retainer cost compare across a 5-entity versus a 15-entity platform?

The platform-level base is comparable across both platforms — calibrated to platform team size and meeting cadence, not entity count. The primary scaling factor is per-acquisition activation fees: a 15-entity platform activates the 90-120 day intensive three times more often than a 5-entity platform over the same hold period. However, per-activation cost typically decreases across the hold period as the Platform Integration Playbook matures — the fourth or fifth entity under the retainer requires less diagnostic groundwork than the first.

What is the minimum engagement scope for the C2 retainer?

The retainer is designed for PE platforms that acquire at least 2-3 entities over the hold period and where the human-layer integration work is sufficient in complexity and recurrence to justify a platform-level methodology. Platforms with a single acquisition target already closed are better served by the single-event Post-Merger Human Integration engagement (C1). Contact IHS if you are unsure which structure fits — the initial consultation is a working conversation, and IHS will tell you directly if C1 is the better fit.

Integral PE-Rollup Culture-Integration Retainer — Cost and Pricing Guide

Last updated: May 2026

IHS does not publish a fixed fee schedule for the Integral PE-Rollup Culture-Integration Retainer (C2). The retainer is scoped per platform — calibrated to acquisition cadence, portfolio size, and the depth of integration support required per entity. This guide explains how PE platform retainers at this level are priced relative to market benchmarks, what drives cost up or down, what the retainer delivers across 12-24 months, and what the documented cost of not engaging looks like across a serial-acquisition hold period. Delivered by Thomas G. Goddard, JD, PhD, CCEP.

Why IHS Does Not Publish Fixed Pricing

The C2 retainer is principal-delivered. Every engagement is scoped to a specific platform's acquisition pace, entity count, clinical-sector mix, founder-clinician transition complexity, and the integration debt the platform is already carrying. There is no productized rate card to publish because there is no productized retainer — each scope is built from the platform's actual conditions.

This is consistent with how every elite human-capital advisory engagement at the PE platform level is structured. Bain does not publish day rates. McKinsey does not publish engagement minimums. The fee is a function of the scope, and the scope cannot be specified without a platform diagnostic. Publishing a number without a scope produces a number that is wrong for every platform — too high for a platform with three entities and a single annual acquisition, too low for a platform in active rollup mode with six entities in the past eighteen months.

What this guide provides instead: the market benchmarks for human-capital consulting at the PE platform level, the factors that drive scope up or down, and a quarterly budget planning framework across the 12-24 month retainer. Contact IHS for a proposal calibrated to your platform.

How C2 Retainer Cost Compares to PE Operating Partner Consulting

The relevant benchmarks for a PE healthcare culture-integration retainer are not generalist HR consulting or organizational development advisory. They are the two categories of senior advisory PE platforms already budget: major-firm strategy and operating-model consulting, and in-house operating partner cost.

Major-Firm Strategy Consulting Day Rates

Senior consultants at Bain & Company, McKinsey & Company, and Boston Consulting Group bill PE clients at $5,000–$10,000 per consultant per day for operating-model and value-creation engagements. Partner-level billing runs higher. A typical 8-week operational-improvement engagement at a major firm runs $500,000–$2,000,000+ depending on team size and scope. These are the firms PE platforms call for financial-model work, commercial diligence, and cost-structure rationalization — the layer adjacent to, but not covering, the human-side integration work the C2 retainer addresses.

In-House Operating Partner Cost

PE-firm operating partners are typically compensated at $500,000–$2,000,000+ annually in total compensation (salary plus carry), per PE industry compensation surveys. Operating partners address operational and commercial levers; they do not address the autonomic state of leadership teams absorbing acquisition after acquisition, the vocation crisis in founder-clinicians cycling through post-close holdback, the relational debt compounding across portfolio entities, or the mid-level leader integration failure driving clinical attrition. The C2 retainer works alongside operating partners — addressing the layer their toolkit cannot reach.

What This Means for the C2 Retainer

A 12-24 month principal-delivered retainer delivering platform-level integration discipline — per-acquisition intensives, founder-clinician transition protocols, quarterly health reviews, and a Platform Pattern-Recognition Report — is priced relative to the Bain/BCG day-rate benchmark for sustained advisory engagement, adjusted for the scope and cadence of a retainer rather than a discrete project. Platforms that have paid $500,000+ for a single major-firm operational engagement understand the reference point. The C2 retainer is sized to deliver sustained human-layer integration capability across the full hold period. Contact IHS for a proposal calibrated to your platform's acquisition cadence and portfolio scope.

Factors That Affect Retainer Cost

Factor	Direction	Explanation
Acquisition pace (entities per year)	Higher pace → higher cost	Each new entity activates a 90-120 day per-acquisition intensive. Two entities per year means two activations; five entities means five. The per-acquisition fee scales with actual cadence, not a projected average.
Platform leadership team size	Larger team → higher base	Senior leadership team work scales with the number of principals in the platform team. A four-person team and a twelve-person team require different session architectures and more time per session.
Founder-clinician transition complexity per entity	Higher complexity → higher per-activation cost	A solo-founder pharmacist who built a single location over 20 years carries a different vocation-grief profile than a multi-site operator already functioning as a manager. The per-acquisition intensive calibrates depth of founder-clinician work to the individual profile.
Mid-level leader integration complexity	Higher complexity → higher per-activation cost	Entities with large clinical-director and department-head cohorts — MBHOs, multi-location specialty pharmacy platforms, large hospice operators — require more intensive mid-level leader integration work than single-location acquisitions with flat management structures.
Prior integration debt at engagement start	Higher debt → higher initial scope	Platforms starting mid-cycle — after several ad-hoc acquisitions — carry accumulated relational debt that must be assessed and partially remediated before the Platform Integration Playbook can be built from a stable baseline. The opening diagnostic scope is larger than for a platform beginning the retainer before its first acquisition.
Playbook maturity across the hold period	Later in retainer → lower per-activation cost	The Platform Integration Playbook compounds. Each per-acquisition intensive refines it; by the third or fourth entity under the retainer, the diagnostic is more precise and the intensive faster. The fourth entity costs less per unit of integration support than the first.
Internal CHRO coordination capacity	Strong CHRO → lower overhead	Platforms with an experienced CHRO who absorbs session scheduling, document logistics, and stakeholder coordination reduce the administrative load on the principal. Platforms without internal HR infrastructure require more coordinator support billed into scope.
Sector mix (specialty pharmacy vs. hospice vs. behavioral health)	Varies by sector	Some sectors carry structurally higher founder-clinician grief intensity (hospice, behavioral health) or more complex mid-level integration dynamics (multi-site MBHOs). Sector mix informs the platform-level base scope at contract.

What You Receive

The C2 retainer delivers seven principal-led outputs across the 12-24 month engagement.

Platform Integration Playbook. Built in months 1-3 from the opening diagnostic; updated at each quarterly health review. The playbook is the primary platform-level asset the retainer produces — a reusable integration methodology the platform owns and can sustain into its next fund cycle.
Per-Acquisition Integration Intensive (90-120 days per entity). Deploys at each new entity close. Covers post-close diagnostic (weeks 1-2), senior leadership team integration sessions separate before joint (weeks 3-8), mid-level leader integration support (weeks 6-12), and founder-clinician transition support (weeks 2-12, calibrated to the founder's readiness).
Founder-Clinician Transition Protocol. Structured individual transition support and a facilitated platform-entity conversation for each acquired founder-clinician. Over the hold period, the platform builds internal capacity to sustain the protocol — capability transfer, not dependency.
Senior Leadership Team Work. Quarterly structured sessions for the platform leadership team addressing activation state, relational dynamics, and the team's capacity to absorb successive entities without compounding the relational debt from prior acquisitions.
Quarterly Platform Integration Health Review. A structured assessment across all portfolio entities producing a platform integration dashboard — integration trajectory, attrition risk flags, mid-level leader cohort status — with intervention-priority recommendations for the next quarter.
Regulatory and Contractual Integration Review. Review of governance documents, employment agreements, non-compete structures, and regulatory constraints for each new entity, incorporated into the per-acquisition intensive before fieldwork begins. The JD and 25+ years of healthcare regulatory experience — including service as COO and General Counsel of URAC — makes this the layer no I/O psychology or culture consulting practice reaches independently.
Platform Pattern-Recognition Report. Delivered at retainer close. Synthesizes integration outcomes across the full portfolio, identifies acquisition profiles and architectures that produced the best human-layer outcomes, and delivers a self-sustaining integration protocol for the platform's next hold period or successor fund.

All deliverables are principal-delivered by Thomas G. Goddard, JD, PhD, CCEP. Survey administration, scheduling, and document logistics are coordinator-supported. Diagnostic synthesis, leadership-team sessions, founder-clinician transition work, mid-level integration sessions, and all platform-level reporting are principal-delivered across the full engagement — not front-loaded to a discovery phase with associate follow-through thereafter.

The Cost of Not Engaging

The financial case for the retainer is built on the documented cost of human-layer integration failure in PE healthcare. These are not projections — they are the empirically documented failure rates in the segment where the retainer operates.

70–90% of M&A deals fail to deliver projected value (MIT Sloan Management Review). Healthcare is not an exception to this pattern — it is closer to the high end of it.
Only 14% of healthcare M&A reaches successful integration (Bain & Company, cited by VALUWIT). The healthcare-specific failure rate exceeds the cross-industry average.
65% of acquiring companies cite cultural issues as hampering post-merger operations (PwC M&A Integration Survey). Cultural integration failure is the primary cited cause of post-merger underperformance — not financial modeling error or operational friction.
PE accounts for more than 90% of physician-practice M&A transactions in 2026 (FOCUS Bankers). The volume of PE healthcare acquisition is at a historic high, and the human-layer failure pattern is repeating at scale across the sector.
82% of U.S. physicians are now employed by hospitals, PE platforms, insurers, or other corporate entities (Avalere/Physicians Advocacy Institute). The workforce PE platforms are acquiring is acutely sensitive to governance structures that fail to protect clinical identity — the precise dynamic the retainer addresses.
LP scrutiny of workforce and culture risk is increasing. Post-2022, institutional LPs are asking PE healthcare platforms for evidence of human-capital integration methodology alongside EBITDA trajectory and revenue-cycle metrics. Platforms that cannot demonstrate a systematic integration discipline face friction in fundraising and LP reporting cycles.
Exit-multiple erosion from clinical attrition. A specialty pharmacy platform that loses its clinical staff in Year 3 of a 5-year hold compresses its exit multiple at precisely the moment the platform should be demonstrating operational maturity. Clinical-staff attrition driven by integration failure is not visible on the balance sheet until it is too late to recover before the exit timeline.

For a platform acquiring 5–30 entities over a 3–7 year hold period, the cost of ad-hoc integration is not the cost of one failed acquisition. It is the compounding cost of repeated human-layer failure at each entity close — relational debt that accumulates across the portfolio, founder-clinicians who exit before the holdback expires, mid-level leaders who go passive rather than productive, and a platform leadership team that exhausts its relational capacity before the fifth acquisition. The retainer is the cost of not repeating that pattern at scale.

How the Retainer Is Structured

The retainer runs in two concurrent tracks across the 12-24 month engagement.

Platform-level base track (continuous). The quarterly health review, playbook maintenance, and senior leadership team work run regardless of acquisition pace. The base is calibrated to the platform's anticipated cadence at contract. A platform between acquisitions uses this period to consolidate prior integration gains and build readiness for the next close.

Per-acquisition intensive track (deployed at each close). The 90-120 day intensive activates when a new entity closes. The activation fee is separate from the platform-level base and is priced per entity. A platform in an active acquisition year may have the per-acquisition track running on two entities simultaneously; per-acquisition fees stack but the platform base does not increase to cover parallel activations.

Contract modification for pace changes. The base is calibrated to anticipated acquisition cadence at contract. Material changes in pace are handled through a contract modification process. Platforms that acquire fewer entities than anticipated retain the platform-level track and the playbook matures regardless of whether a new entity has closed.

Engagement terms are documented in an engagement letter before any fieldwork begins. The engagement letter addresses scope, per-acquisition activation fees, confidentiality protocol, and the interaction of the retainer with the platform's post-close governance and information-sharing constraints.

Budget Planning by Quarter

Quarter 1 — Platform Diagnostic and Playbook Development

Opening diagnostic of the platform leadership team and existing portfolio entities
Platform Integration Playbook development (primary deliverable of Q1)
Senior leadership team baseline sessions
Engagement letter and confidentiality protocol execution
If a new entity closes during Q1: per-acquisition intensive activation (additional activation fee)

Quarters 2-4 — Per-Acquisition Intensives and Quarterly Reviews

Platform-level base: quarterly health review plus senior leadership team sessions each quarter
Per-acquisition intensive activation for each new entity closing in the quarter
Founder-clinician transition protocol for each acquired entity
Mid-level leader integration support per acquired entity
Platform integration dashboard update with intervention-priority recommendations

Quarters 5-8 (24-Month Engagement)

Continued platform-level base and per-acquisition activations at refined playbook maturity
Playbook refinements incorporating portfolio pattern learning from prior activations
Cross-entity mid-level leader convenings (quarterly, platform-wide)
LP-ready workforce and integration metrics for fund reporting
Platform Pattern-Recognition Report (delivered at engagement close)

Budget Planning Guidance

Platforms planning a multi-year integration retainer should build a base budget for the platform-level track (fixed across the engagement) and a variable budget for per-acquisition activations calibrated to anticipated deal cadence. Variable budget should include a contingency for pace acceleration — platforms in active rollup mode consistently acquire at the high end of their anticipated range. Contact IHS to build a proposal with a base fee and per-activation fee structure that matches your platform's deal pipeline.

Frequently Asked Questions

Why does IHS not publish a fee schedule for the retainer?

No PE operating-model or human-capital advisory firm at this level publishes day rates publicly. The fee is a function of the scope; the scope cannot be specified without a platform diagnostic. This guide provides the market benchmarks — Bain/BCG day rates, operating-partner compensation ranges — that give a realistic reference point without false precision that would mislead rather than inform every platform that reads it.

How does the retainer fee compare to hiring an internal integration officer?

A dedicated VP-level integration officer at a PE-backed platform runs $300,000–$600,000 in annual total compensation (salary plus bonus, excluding equity). The retainer provides principal-level advisory at the JD, PhD, CCEP credential level — a credential intersection that no internal hire at that compensation range reaches — on a retainer structure rather than a full-time headcount. For platforms in active acquisition mode, the retainer provides deeper specialist expertise per dollar than an internal hire who also carries operational responsibilities outside integration.

Can the retainer absorb existing portfolio companies not yet fully integrated?

Yes. Platforms starting mid-cycle include an expanded opening diagnostic that assesses the integration debt accumulated across the portfolio. The Platform Integration Playbook is built from that baseline, and prior-entity integration work is incorporated into the Q1-Q2 scope. The fee structure for a mid-cycle start reflects the additional diagnostic and remediation scope. Contact IHS to discuss structuring for your platform's current state.

Is the per-acquisition intensive fee fixed or variable?

The per-acquisition activation fee is scoped to the specific entity at close — calibrated to the founder-clinician profile, mid-level leader cohort size, cultural distance from the platform, and sector-specific integration complexity. Platforms that close acquisitions of broadly comparable size and profile can expect per-activation fees that converge toward a consistent range. Platforms with highly variable acquisition profiles will see more variation in per-activation fees across the hold period.

What is the minimum engagement scope?

The retainer is designed for PE platforms acquiring at least 2-3 entities over the hold period where the human-layer integration work is sufficient in complexity and recurrence to justify a platform-level methodology. Platforms with a single acquisition already closed are better served by the single-event Post-Merger Human Integration engagement (C1). The initial consultation is a working conversation — IHS will tell you directly if C1 is the better fit.

How does the retainer intersect with legal and regulatory advisors already engaged by the platform?

The regulatory and contractual integration review in C2 covers the human-layer dimensions of governance documents, employment agreements, and non-compete structures as they bear on integration fieldwork — not the deal-level legal review that M&A counsel conducts at close. The two are complementary. The JD credential and 25+ years of healthcare regulatory experience allow IHS to read and interpret those constraints without requiring a handoff from the platform's lawyers at each activation.

How is the retainer billed?

Billing structure is negotiated in the engagement letter. Most platform retainers are structured with a monthly platform-level base fee and per-acquisition activation fees billed at the start of each intensive deployment. Platforms with specific fund-accounting or LP-reporting requirements can request quarterly billing, milestone-based billing, or annual prepayment. IHS accommodates the platform's fund-document and accounting conventions; billing structure does not change scope or fee.

What happens if the platform's acquisition pace is significantly lower than anticipated?

The platform-level base continues regardless of acquisition pace. A platform in a quiet integration period uses that time to consolidate prior integration gains, deepen the playbook's pattern learning, and build platform leadership team capacity for the next close. If acquisition pace drops below a threshold that no longer justifies the base retainer, IHS will raise that directly and discuss whether a modified structure or pause-and-resume provision serves the platform better.

Related Resources

Ready to Build the Integration Discipline Your Platform Needs?

The initial consultation is a working conversation about your platform's acquisition pace, where the human-layer integration challenges are concentrating, and how the C2 retainer is scoped for your specific portfolio. If IHS is not the right fit, we will tell you directly.

Schedule a Free Discovery Session